- POSITIVE
Quarterly Revenue Dr. Reddy's Labs Sep-2026 Quarterly Revenue is Rs 5,790 Cr which is growth of 16.2% YoY.
- POSITIVE
Quarterly Net Profit Dr. Reddy's Labs Sep-2026 Quarterly Net Profit is Rs 696 Cr which is growth of 79.7% YoY.
1400.902.70(0.19%)
1.5M
NSE+BSE Volume
NSE 19 Nov, 2026 3:31 PM
Dr. Reddy's Labs quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents
Forecaster Analyst Estimates for Dr. Reddy's Labs share price target, revenues, EPS, net income and more
Dr. Reddy's Labs quarterly results: revenue, profit, and P&L – 13 quarter history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
| Indicator | Graph | Sep '26 | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5,789.9 | 5,577 | 4,389.2 | 4,643 | 4,982.8 | 8,207.8 | 5,977.3 | 5,250.4 | 6,903.9 | 6,059 | 5,317.5 | 4,330.6 | 5,061.8 | ||
Operating Exp. | 4,489.4 | 4,687.7 | 4,200.8 | 4,183.1 | 4,138.3 | 3,972.5 | 4,016.3 | 3,822.6 | 3,974.7 | 3,888.2 | 3,700.2 | 3,446.7 | 3,209.6 | |
Operating Profit | 1,094.7 | 447.4 | -499.9 | 99.6 | 480.3 | 3,837 | 1,443 | 1,192.4 | 2,721.6 | 1,953 | 1,378.6 | 656.3 | 1,629.1 | |
Operating Profit Margin % | 19.64% | 8.71% | -13.08% | 2.33% | 10.40% | 49.13% | 25.94% | 23.78% | 40.64% | 33.43% | 27.01% | 16.00% | 33.67% | |
Depr. | 333.7 | 317.7 | 318.5 | 314.3 | 294.8 | 279.8 | 264.5 | 265.1 | 260 | 249.8 | 246.2 | 246.4 | 245.8 | |
Interest | 77 | 73.1 | 54.3 | 41.4 | 33.4 | 19.2 | 31.1 | 43.3 | 28.4 | 7.1 | 5.9 | 5.6 | 5.8 | |
Profit Before Tax | 901.3 | 497 | -305.5 | 104.2 | 516.3 | 3,936.3 | 1,561.8 | 1,119.4 | 2,640.8 | 1,913.9 | 1,339.2 | 631.9 | 1,600.6 | |
Tax | 205.5 | 92.3 | -86.1 | 13.6 | 129 | 975.1 | 361.1 | 270 | 758.7 | 496.7 | 304.4 | 156.7 | 408 | |
Net Profit | 695.8 | 404.7 | -219.4 | 90.6 | 387.3 | 2,961.2 | 1,200.7 | 849.4 | 1,882.1 | 1,417.2 | 1,034.8 | 475.2 | 1,192.6 | |
EPS Adj. latest | 8.3 | 4.9 | -2.6 | 1.1 | 4.6 | 35.5 | 14.4 | 10.2 | 22.6 | 17 | 12.4 | 5.7 | 14.3 | |
Net profit TTM | 971.7 | 663.2 | 3,219.7 | 4,639.8 | 5,398.6 | 6,893.4 | 5,349.4 | 5,183.5 | 4,809.3 | 4,119.8 | 4,342 | 3,979.6 | 3,829 | |
Basic EPS TTM | 11.6 | 7.9 | 38.6 | 55.6 | 64.7 | 82.6 | 64.1 | 62.2 | 288.3 | 247 | 260.3 | 238.6 | 229.6 | |
Earnings Transcripts | ||||||||||||||
Results PDF | ||||||||||||||
Result Notes |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Dr. Reddy's Labs competitor comparison and performance snapshot within industry
Dr. Reddy's Labs revenue mix: sales, profit, and capital employed breakups by segment
Dr. Reddy's Labs annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- NEGATIVE
Annual Revenue Dr. Reddy's Labs Mar-2026 Annual Revenue is Rs 22,222 Cr which is growth of -7.9% YoY.
- NEGATIVE
Annual Net Profit Dr. Reddy's Labs Mar-2026 Annual Net Profit is Rs 3,220 Cr which is growth of -39.8% YoY.
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
-7.9%
2Y CAGR
4.5%
3Y CAGR
8.2%
5Y CAGR
9.4%
7Y CAGR
10.8%
10Y CAGR
7.8%
Total Revenue Annual is falling faster than historical averages.
Net Profit Ann.
1Y CHG
-39.8%
2Y CAGR
-13.9%
3Y CAGR
7.2%
5Y CAGR
8%
7Y CAGR
14.1%
10Y CAGR
9%
Net Profit Annual is falling faster than historical averages.
Operating Exp. Ann.
1Y CHG
5.6%
2Y CAGR
10.7%
3Y CAGR
9.2%
5Y CAGR
10.2%
7Y CAGR
10.4%
10Y CAGR
7.9%
Operating Expenses Annual Cr growth is lower than historical averages.
Dr. Reddy's Labs balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Total Shareholders Fund Dr. Reddy's Labs Mar-2026 Total Shareholders Fund is Rs 31,366 Cr which is growth of 8.7% YoY.
- POSITIVE
Total Assets Dr. Reddy's Labs Mar-2026 Total Assets is Rs 43,602 Cr which is growth of 13.9% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
15.3% | 13.1% | 31,365.6 | 28,856.6 | 24,240.8 | 20,474.2 | 18,336.2 | 16,983.7 | 15,191.9 | 12,684.1 | 11,807.8 | 11,600.6 | 11,605.4 | ||
Minority Interest Liability Ann. | - | - | - | - | - | - | - | - | - | - | - | - | - | |
33.4% | 66.5% | 1,094 | 782.5 | 580.4 | 460.9 | 114.3 | 85.6 | 103.4 | 484.1 | 572.6 | 588.6 | 1,153.5 | ||
35.9% | 19.6% | 11,142.5 | 8,651.8 | 5,538.1 | 4,439.7 | 6,045.1 | 4,560.3 | 4,180.5 | 3,079.3 | 4,719.9 | 4,258 | 4,798.7 | ||
Total Capital Plus Liabilities Ann. | 19.8% | 15.1% | 43,602.1 | 38,290.9 | 30,359.3 | 25,374.8 | 24,495.6 | 21,629.6 | 19,475.8 | 16,247.5 | 17,100.3 | 16,447.2 | 17,557.6 | |
14.2% | 12.4% | 12,099.2 | 10,429.2 | 8,800.1 | 8,119.7 | 7,350.8 | 6,745.1 | 4,845.7 | 5,082.8 | 5,392.3 | 5,382.1 | 5,044.3 | ||
29.4% | 18.6% | 25,078.9 | 21,787.9 | 12,543.4 | 11,586.5 | 11,012 | 10,685.4 | 9,369.1 | 7,314.3 | 8,061.8 | 7,853.4 | 7,462.7 | ||
10.3% | 11.1% | 18,523.2 | 16,503 | 17,815.9 | 13,788.3 | 13,483.6 | 10,944.2 | 10,106.7 | 8,933.2 | 9,038.5 | 8,593.8 | 10,094.9 | ||
Total Assets Ann. | 19.8% | 15.1% | 43,602.1 | 38,290.9 | 30,359.3 | 25,374.8 | 24,495.6 | 21,629.6 | 19,475.8 | 16,247.5 | 17,100.3 | 16,447.2 | 17,557.6 | |
Contingent Liabilities plus Commitments Ann. | 14% | 3% | 1,229.2 | 1,500.2 | 1,763.6 | 830.2 | 827.4 | 1,062.8 | 1,068.6 | 696.5 | 716.7 | 707.9 | 972.6 | |
Bonus Equity Share Capital Ann. | 0% | 0% | 55.9 | 55.9 | 55.9 | 55.9 | 55.9 | 55.9 | 55.9 | 55.9 | 55.9 | 55.9 | 55.9 | |
Non Current Investments Unquoted Book Value Ann. | - | - | 12,361.3 | 10,301.8 | 4,033 | 135.4 | 1,968.8 | |||||||
Current Investments Unquoted Book Value Ann. | - | - | 3,233.5 | 2,883 | 1,682.8 | 1,299.1 | 2,112.2 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Assets Ann.
1Y CHG
13.9%
2Y CAGR
19.8%
3Y CAGR
19.8%
5Y CAGR
15.1%
7Y CAGR
15.1%
10Y CAGR
9.5%
Total Assets Annual growth is lower than historical averages.
Total Current Liabilities Ann.
1Y CHG
28.8%
2Y CAGR
41.8%
3Y CAGR
35.9%
5Y CAGR
19.6%
7Y CAGR
20.2%
10Y CAGR
8.8%
Total Current Liabilities Annual Cr growth is stable compared to historical averages.
Total ShareHolders Funds Ann.
1Y CHG
8.7%
2Y CAGR
13.8%
3Y CAGR
15.3%
5Y CAGR
13.1%
7Y CAGR
13.8%
10Y CAGR
10.5%
Total ShareHolders Funds Annual growth is lower than historical averages.
Dr. Reddy's Labs ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Book Value Per Share Dr. Reddy's Labs Mar-2026 Book Value Per Share is 376 Rs which is growth of 8.6% YoY.
- POSITIVE
ROE Dr. Reddy's Labs Mar-2026 ROE is 10% which is growth of 8.3% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BVSH Ann. | -32.6% | -18.1% | 375.6 | 346 | 1,453.3 | 1,228.9 | 1,101.9 | 1,020.7 | 914.1 | 764.1 | 711.3 | 699.7 | 680.3 | |
RoA Ann. % | -10.5% | -6.1% | 7.38% | 13.97% | 14.30% | 10.29% | 6.62% | 10.10% | 15.08% | 7.86% | 3.31% | 8.41% | 7.71% | |
ROE Ann. % | -7% | -4.4% | 10.26% | 18.53% | 17.91% | 12.76% | 8.85% | 12.87% | 19.33% | 10.07% | 4.80% | 11.93% | 11.67% | |
ROCE Ann. % | -9.9% | -5.7% | 13.55% | 24.78% | 23.41% | 18.54% | 12.25% | 18.17% | 18.46% | 13.34% | 6.13% | 13.14% | 15.67% | |
Total Debt to Total Equity Ann. | 0.2 | 0.1 | 0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
ROE Ann. %
1Y CHG
-44.6%
2Y CAGR
-24.3%
3Y CAGR
-7%
5Y CAGR
-4.4%
7Y CAGR
0.3%
10Y CAGR
-1.3%
ROE Annual % is falling faster than historical averages.
RoA Ann. %
1Y CHG
-47.2%
2Y CAGR
-28.2%
3Y CAGR
-10.5%
5Y CAGR
-6.1%
7Y CAGR
-0.9%
10Y CAGR
-0.4%
RoA Annual % is falling faster than historical averages.
Current Ratio Ann.
1Y CHG
-10.5%
2Y CAGR
-27.1%
3Y CAGR
-18.1%
5Y CAGR
-6.7%
7Y CAGR
-7.3%
10Y CAGR
-2.1%
Current Ratio Annual is falling faster than historical averages.
Dr. Reddy's Labs cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Cash From Operating Activity Dr. Reddy's Labs Mar-2026 Cash From Operating Activity is Rs 4,660 Cr which is growth of 10.3% YoY.
- NEGATIVE
Net Cash Flow Dr. Reddy's Labs Mar-2026 Net Cash Flow is Rs -7 Cr which is growth of -106.3% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
-2.7% | 5.8% | 4,660.5 | 4,225 | 3,449.7 | 5,052.9 | 1,338.7 | 3,514.2 | 1,839.2 | 2,762.1 | 1,538.6 | 1,015.9 | 2,798.2 | ||
Cash from Investing Act. Ann. | - | - | -5,784.7 | -5,697.6 | -3,430.3 | -3,447.6 | -2,038 | -1,458 | -1,689.2 | -550.9 | -1,179.9 | 1,442.5 | -1,961.1 | |
Cash from Financing Act. Ann. | - | - | 1,116.8 | 1,590.7 | 68.1 | -2,696.9 | 505.5 | -794.3 | -224.1 | -2,223.1 | -304.4 | -2,581.8 | -693.7 | |
- | - | -7.4 | 118.1 | 87.5 | -1,091.6 | -193.8 | 1,261.9 | -74.1 | -11.9 | 54.3 | -123.4 | 143.4 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Cash from Operating Act. Ann.
1Y CHG
10.3%
2Y CAGR
16.2%
3Y CAGR
-2.7%
5Y CAGR
5.8%
7Y CAGR
7.8%
10Y CAGR
5.2%
Cash from Operating Activity Annual growth is higher than historical averages.
Cash from Financing Act. Ann.
1Y CHG
-29.8%
2Y CAGR
305%
Cash from Financing Annual Activity is falling faster than historical averages.
